1H NMR-based metabonomics in brain nucleus accumbens and striatum following repeated cocaine treatment in rats

Neuroscience

Volumn 218, Issue , 2012, Pages 196-205

  Li, Y ^a   Yan, G Y ^a   Zhou, J Q ^a   Bu, Q ^a   Deng, P C ^b   Yang, Y Z ^a   Lv, L ^a   Deng, Y ^a   Zhao, J X ^a   Shao, X ^a   Zhu, R M ^a   Huang, Y N ^a   Zhao, Y L ^a   Cen, X B ^a  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

Cocaine; Conditioned place preference; Metabonomics; Nuclear magnetic resonance

Indexed keywords

4 AMINOBUTYRIC ACID; CHOLINE; COCAINE; CREATINE; GLUTAMIC ACID; GLYCEROL; INOSITOL; LACTIC ACID; N ACETYLASPARTIC ACID; PHOSPHORYLCHOLINE; TAURINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOMICS; BRAIN TISSUE; CONTROLLED STUDY; CORPUS STRIATUM; DISORDERS OF MITOCHONDRIAL FUNCTIONS; MALE; MEMBRANE DAMAGE; METABOLITE; METABONOMICS; NONHUMAN; NUCLEUS ACCUMBENS; OXIDATIVE STRESS; PARTIAL LEAST SQUARES REGRESSION; PATTERN RECOGNITION; PLACE PREFERENCE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RAT;

ANIMALS; COCAINE; CORPUS STRIATUM; DOPAMINE UPTAKE INHIBITORS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; METABOLOMICS; NUCLEUS ACCUMBENS; RATS; RATS, WISTAR;

EID: 84863784933     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2012.05.019     Document Type: Article

References (65)

1. Bollard M.E., Stanley E.G., Lindon J.C., Nicholson J.K., Holmes E. NMR-based metabonomic approaches for evaluating physiological influences on biofluid composition. NMR Biomed 2005, 18:143-162.
2. Borgkvist A., Mrejeru A., Sulzer D. Multiple personalities in the ventral tegmental area. Neuron 2011, 70:803-805.
3. Bowers M.S., Kalivas P.W. Forebrain astroglial plasticity is induced following withdrawal from repeated cocaine administration. Eur J Neurosci 2003, 17:1273-1278.
4. Bu Q., Yan G., Deng P., Peng F., Lin H., Xu Y., Cao Z., Zhou T., Xue A., Wang Y. NMR-based metabonomic study of the sub-acute toxicity of titanium dioxide nanoparticles in rats after oral administration. Nanotechnology 2009, 21:125105.
5. Chakraborty G., Mekala P., Yahya D., Wu G., Ledeen R.W. Intraneuronal N-acetylaspartate supplies acetyl groups for myelin lipid synthesis: evidence for myelin-associated aspartoacylase. J Neurochem 2001, 78:736-745.
6. Cosgrove K.P. Imaging receptor changes in human drug abusers. Curr Top Behav Neurosci 2011, 199-217.
7. Dalley J.W., Fryer T.D., Brichard L., Robinson E.S.J., Theobald D.E.H., Lne K., Pea Y., Murphy E.R., Shah Y., Probst K. Nucleus accumbens D2/3 receptors predict trait impulsivity and cocaine reinforcement. Science 2007, 315:1267-1270.
8. Demougeot C., Marie C., Giroud M., Beley A. N-acetylaspartate: a literature review of animal research on brain ischaemia. J Neurochem 2004, 90:776-783.
9. Ericson M., Chau P.P., Clarke R.B., Adermark L., Sderpalm B. Rising taurine and ethanol concentrations in nucleus accumbens interact to produce dopamine release after ethanol administration. Addict Biol 2011, 16:377-386.
10. Freeman W.M., Patel K.M., Brucklacher R.M., Lull M.E., Erwin M., Morgan D., Roberts D.C.S., Vrana K.E. Persistent alterations in mesolimbic gene expression with abstinence from cocaine self-administration. Neuropsychopharmacology 2007, 33:1807-1817.
11. 1H NMR spectroscopy. Neurochem Int 2007, 50:386-394.
12. Garrod S., Bollard M.E., Nicholls A.W., Connor S.C., Connelly J., Nicholson J.K., Holmes E. Integrated metabonomic analysis of the multiorgan effects of hydrazine toxicity in the rat. Chem Res Toxicol 2005, 18:115-122.
13. Gavaghan C., Wilson I., Nicholson J. Physiological variation in metabolic phenotyping and functional genomic studies: use of orthogonal signal correction and PLS-DA. FEBS Lett 2002, 530:191-196.
14. Holten A.T., Gundersen V. Glutamine as a precursor for transmitter glutamate, aspartate and GABA in the cerebellum: a role for phosphate-activated glutaminase. J Neurochem 2008, 104:1032-1042.
15. Huxtable R.J. Physiological actions of taurine. Psychol Rev 1992, 72:101-163.
16. Jalil M. Reduced N-acetylaspartate levels in mice lacking aralar, a brain-and muscle-type mitochondrial aspartate-glutamate carrier. J Biol Chem 2005, 280:31333-31339.
17. Jouvert P., Revel M.O., Lazaris A., Aunis D., Langley K., Zwiller J. Activation of the cGMP pathway in dopaminergic structures reduces cocaine-induced EGR-1 expression and locomotor activity. J Neurosci 2004, 24:10716-10725.
18. 1H-NMR-based metabolomics study of cerebral infarction. Stroke 2011, 42:1282-1288.
19. Kaddurah-Daouk R., Krishnan K.R.R. Metabolomics: a global biochemical approach to the study of central nervous system diseases. Neuropsychopharmacology 2008, 34:173-186.
20. Kalivas P., Volkow N. New medications for drug addiction hiding in glutamatergic neuroplasticity. Mol Psychiatry 2011, 16(10):974-986.
21. Kaminski R.M., Nú ez-Taltavull J.F., Budziszewska B., Lasoń W., Gasior M., Zapata A., Shippenberg T.S., Witkin J.M. Effects of cocaine-kindling on the expression of NMDA receptors and glutamate levels in mouse brain. Neurochem Res 2011, 36:146-152.
22. Kaul S., Faiman M.D., Lunte C.E. Determination of GABA, glutamate and carbamathione in brain microdialysis samples by capillary electrophoresis with fluorescence detection. Electrophoresis 2011, 32:284-291.
23. Knackstedt L.A., Melendez R.I., Kalivas P.W. Ceftriaxone restores glutamate homeostasis and prevents relapse to cocaine seeking. Biol Psychiatry 2010, 67:81-84.
24. Lan M., McLoughlin G., Griffin J., Tsang T., Huang J., Yuan P., Manji H., Holmes E., Bahn S. Metabonomic analysis identifies molecular changes associated with the pathophysiology and drug treatment of bipolar disorder. Mol Psychiatry 2008, 14:269-279.
25. LaPlant Q., Vialou V., Covington H.E., Dumitriu D., Feng J., Warren B.L., Maze I., Dietz D.M., Watts E.L., Iiguez S.D. Dnmt3a regulates emotional behavior and spine plasticity in the nucleus accumbens. Nat Neurosci 2010, 13:1137-1143.
26. Li F., Xue Y., Wang J., Fang Q., Li Y., Zhu W.L., He Y., Liu J., Xue L., Shaham Y. Basolateral amygdala cdk5 activity mediates consolidation and reconsolidation of memories for cocaine cues. J Neurosci 2010, 30(31):10351-10359.
27. Li Y., Xue Y., He Y., Li F., Xue L., Xu C., Sacktor T.C., Shaham Y., Lu L. Inhibition of PKMζ in nucleus accumbens core abolishes long-term drug reward memory. J Neurosci 2011, 31:5436-5446.
28. Liu X., Jensen J.E., Gillis T.E., Zuo C.S., Prescot A.P., Brimson M., Cayetano K., Renshaw P.F., Kaufman M.J. Chronic cocaine exposure induces putamen glutamate and glutamine metabolite abnormalities in squirrel monkeys. Psychopharmacology 2011, 1-9.
29. MacKay S., Meyerhoff D.J., Dillon W.P., Weiner M.W., Fein G. Alteration of brain phospholipid metabolites in cocaine-dependent polysubstance abusers. Biol Psychiatry 1993, 34:261-264.
30. Maus M., Marin P., Isral M., Glowinski J., Prémont J. Pyruvate and lactate protect striatal neurons against N-methyl-d-aspartate-induced neurotoxicity. Eur J Neurosci 1999, 11:3215-3224.
31. Maze I., Covington H.E., Dietz D.M., LaPlant Q., Renthal W., Russo S.J., Mechanic M., Mouzon E., Neve R.L., Haggarty S.J. Essential role of the histone methyltransferase G9a in cocaine-induced plasticity. Science 2010, 327:213-216.
32. Moffett J.R., Ross B., Arun P., Madhavarao C.N., Namboodiri A. N-acetylaspartate in the CNS: from neurodiagnostics to neurobiology. Prog Neurobiol 2007, 81:89-131.
33. Muriach M., López-Pedrajas R., Barcia J.M., Sanchez-Villarejo M.V., Almansa I., Romero F.J. Cocaine causes memory and learning impairments in rats: involvement of nuclear factor kappa B and oxidative stress, and prevention by topiramate. J Neurochem 2010, 114:1032-1042.
34. Ni Y., Su M., Lin J., Wang X., Qiu Y., Zhao A., Chen T., Jia W. Metabolic profiling reveals disorder of amino acid metabolism in four brain regions from a rat model of chronic unpredictable mild stress. FEBS Lett 2008, 582:2627-2636.
35. Nicholson J.K., Connelly J., Lindon J.C., Holmes E. Metabonomics: a platform for studying drug toxicity and gene function. Nat Rev Drug Discov 2002, 1:153-162.
36. Numa R., Baron M., Kohen R., Yaka R. Tempol attenuates cocaine-induced death of PC12 cells through decreased oxidative damage. Eur J Pharmacol 2011, 650:157-162.
37. Numa R., Kohen R., Poltyrev T., Yaka R. Tempol diminishes cocaine-induced oxidative damage and attenuates the development and expression of behavioral sensitization. Neuroscience 2008, 155:649-658.
38. Oja S.S., Saransaari P. Pharmacology of taurine. Proc West Pharmacol Soc 2007, 50:8-15.
39. Patkar A., Rozen S., Mannelli P., Matson W., Pae C., Krishnan K., Kaddurah-Daouk R. Alterations in tryptophan and purine metabolism in cocaine addiction: a metabolomic study. Psychopharmacology 2009, 206:479-489.
40. 1H NMR-based metabolomics indicates a neurotransmitter cycling deficit in cerebral tissue from a mouse model of Batten disease. J Biol Chem 2005, 280:42508-42514.
41. Pellerin L. Lactate as a pivotal element in neuron-glia metabolic cooperation. Neurochem Int 2003, 43:331-338.
42. Pierce R.C., Bell K., Duffy P., Kalivas P.W. Repeated cocaine augments excitatory amino acid transmission in the nucleus accumbens only in rats having developed behavioral sensitization. J Neurosci 1996, 16:1550-1560.
43. Renthal W., Maze I., Krishnan V., Covington H.E., Xiao G., Kumar A., Russo S.J., Graham A., Tsankova N., Kippin T.E. Histone deacetylase 5 epigenetically controls behavioral adaptations to chronic emotional stimuli. Neuron 2007, 56:517-529.
44. Rosemberg D.B., da Rocha R.F., Rico E.P., Zanotto-Filho A., Dias R.D., Bogo M.R., Bonan C.D., Moreira J.C.F., Klamt F., Souza D.O. Taurine prevents enhancement of acetylcholinesterase activity induced by acute ethanol exposure and decreases the level of markers of oxidative stress in zebrafish brain. Neuroscience 2010, 171:683-692.
45. Ross B.M., Moszczynska A., Peretti F.J., Adams V., Schmunk G.A., Kalasinsky K.S., Ang L., Mamalias N., Turenne S.D., Kish S.J. Decreased activity of brain phospholipid metabolic enzymes in human users of cocaine and methamphetamine. Drug Alcohol Depend 2002, 67:73-79.
46. Russo S.J., Wilkinson M.B., Mazei-Robison M.S., Dietz D.M., Maze I., Krishnan V., Renthal W., Graham A., Birnbaum S.G., Green T.A. Nuclear factor κB signaling regulates neuronal morphology and cocaine reward. J Neurosci 2009, 29:3529-3537.
47. Sánchez-Serrano S., Cruz S., Lamas M. Repeated toluene exposure modifies the acetylation pattern of histones H3 and H4 in the rat brain. Neurosci Lett 2011, 489:142-147.
48. Sa Santos S., Sonnewald U., Carrondo M.J.T., Alves P.M. The role of glia in neuronal recovery following anoxia: in vitro evidence of neuronal adaptation. Neurochem Int 2011, 58:665-675.
49. Salek R., Colebrooke R., Macintosh R., Lynch P., Sweatman B., Emson P., Griffin J. A metabolomic study of brain tissues from aged mice with low expression of the vesicular monoamine transporter 2 (VMAT2) gene. Neurochem Res 2008, 33:292-300.
50. Senaratne R., Milne A.M., MacQueen G.M., Hall G.B.C. Increased choline-containing compounds in the orbitofrontal cortex and hippocampus in euthymic patients with bipolar disorder: a proton magnetic resonance spectroscopy study. Psychiatry Res Neuroimaging 2009, 172:205-209.
51. Thomas M.J., Malenka R.C. Synaptic plasticity in the mesolimbic dopamine system. Philos Trans R Soc Lond B Biol Sci 2003, 358:815-819.
52. Ungless M.A., Whistler J.L., Malenka R.C., Bonci A. Single cocaine exposure in vivo induces long-term potentiation in dopamine neurons. Nature 2001, 411:583-587.
53. Valjent E., Corbillé A.G., Bertran-Gonzalez J., Hervé D., Girault J.A. Inhibition of ERK pathway or protein synthesis during reexposure to drugs of abuse erases previously learned place preference. Proc Natl Acad Sci USA 2006, 103:2932-2937.
54. Wang X., Zhao T., Qiu Y., Su M., Jiang T., Zhou M., Zhao A., Jia W. Metabonomics approach to understanding acute and chronic stress in rat models. J Proteome Res 2009, 8:2511-2518.
55. Wikoff W., Pendyala G., Siuzdak G., Fox H. Metabolomic analysis of the cerebrospinal fluid reveals changes in phospholipase expression in the CNS of SIV-infected macaques. J Clin Invest 2008, 118(7):2661-2669.
56. Wold S., Antti H., Lindgren F., hman J. Orthogonal signal correction of near-infrared spectra. Chemomet Intell Lab Syst 1998, 44:175-185.
57. Wu H., Jin Y., Wei J., Jin H., Sha D., Wu J.Y. Mode of action of taurine as a neuroprotector. Brain Res 2005, 1038:123-131.
58. Xi Z.X., Ramamoorthy S., Shen H., Lake R., Samuvel D.J., Kalivas P.W. GABA transmission in the nucleus accumbens is altered after withdrawal from repeated cocaine. J Neurosci 2003, 23:3498-3505.
59. Yablonsky-Alter E., Agovic M.S., Gashi E., Lidsky T.I., Friedman E., Banerjee S.P. Cocaine challenge enhances release of neuroprotective amino acid taurine in the striatum of chronic cocaine treated rats: a microdialysis study. Brain Res Bull 2009, 79:215-218.
60. Yan G., Zhao Y., Deng P., Lv L., Wang Y., Bu Q., Liu B., Hu C., Zhuo Y., Yang X. Investigation of toxicological effects of Shuanghuanglian injection in Beagle dogs by metabonomic and traditional approaches. Exp Biol Med (Maywood) 2010, (23):1356-1364.
61. 1H-MRS study using TE-averaged PRESS at 3T with an optimized quantification strategy. Psychiatry Res 2009, 174:171-176.
62. Yang S.O., Hyun S.H., Kim S.H., Kim H., Lee J., Whang W.K., Lee M.W., Choi H.K. Differentiation of roots of glycyrrhiza species by H nuclear magnetic resonance spectroscopy and multivariate statistical analysis. Bull Korean Chem Soc 2010, 31:825-828.
63. Yao F.S., Caserta M.T., Wyrwicz A.M. In vitro proton and phosphorus NMR spectroscopic analysis of murine (C57Bl/6J) brain development. NMR Biomed 1999, 12:463-470.
64. Zhang X., Liu H., Wu J., Liu M., Wang Y. Metabonomic alterations in hippocampus, temporal and prefrontal cortex with age in rats. Neurochem Int 2009, 54:481-487.
65. Zhou J., Li Y., Yan G., Bu Q., Lv L., Yang Y., Zhao J., Shao X., Deng Y., Zhu R. Protective role of taurine against morphine-induced neurotoxicity in C6 cells via inhibition of oxidative stress. Neurotox Res 2011, 20(4):334-342.